Advertisement
Screener

ACCELERON PHARMA INC. Reimbursement Revenue (Deprecated 2018-01-31)

ACCELERON PHARMA INC. Reimbursement Revenue (Deprecated 2018-01-31)

ACCELERON PHARMA INC. reported Reimbursement Revenue (Deprecated 2018-01-31) of $3.23 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.

Discontinued › Income Statement › Other Income

us-gaap:ReimbursementRevenue · last filed 2018-05-08

  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $3.23M, a 9.47% decline year-over-year.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.57M, a 10.39% increase year-over-year.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.88M, a 0.31% increase year-over-year.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.92M, a 4.51% decline year-over-year.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2017 was $12.94M, a 5.88% increase from fiscal 2016.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2016 was $12.22M, a 27.74% decline from fiscal 2015.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2015 was $16.91M, a 30.51% increase from fiscal 2014.
  • ACCELERON PHARMA INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2014 was $12.96M, a 2.43% decline from fiscal 2013.
Period endReimbursement Revenue (Deprecated 2018-01-31) 3 monthReimbursement Revenue (Deprecated 2018-01-31) 6 monthReimbursement Revenue (Deprecated 2018-01-31) 9 monthReimbursement Revenue (Deprecated 2018-01-31) 12 month
2018-03-31$3.23M
10-Q · filed 2018-05-08
$6.80M
derived: sum of 2 quarters · filed 2018-05-08
$9.68M
derived: sum of 3 quarters · filed 2018-05-08
$12.60M
derived: sum of 4 quarters · filed 2018-05-08
2017-12-31$3.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$6.45M
derived: sum of 2 quarters · filed 2018-02-27
$9.37M
derived: sum of 3 quarters · filed 2018-02-27
$12.94M
10-K · filed 2018-02-27
2017-09-30$2.88M
10-Q · filed 2017-11-07
$5.80M
derived: sum of 2 quarters · filed 2017-11-07
$9.37M
10-Q · filed 2017-11-07
$12.61M
derived: sum of 4 quarters · filed 2018-05-08
2017-06-30$2.92M
10-Q · filed 2017-08-03
$6.49M
10-Q · filed 2017-08-03
$9.73M
derived: sum of 3 quarters · filed 2018-05-08
$12.60M
derived: sum of 4 quarters · filed 2018-05-08
2017-03-31$3.57M
10-Q · filed 2018-05-08
$6.80M
derived: sum of 2 quarters · filed 2018-05-08
$9.67M
derived: sum of 3 quarters · filed 2018-05-08
$12.73M
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31$3.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$6.10M
derived: sum of 2 quarters · filed 2018-02-27
$9.16M
derived: sum of 3 quarters · filed 2018-02-27
$12.22M
10-K · filed 2018-02-27
2016-09-30$2.87M
10-Q · filed 2017-11-07
$5.93M
derived: sum of 2 quarters · filed 2017-11-07
$8.99M
10-Q · filed 2017-11-07
$12.61M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$3.06M
10-Q · filed 2017-08-03
$6.12M
10-Q · filed 2017-08-03
$9.74M
derived: sum of 3 quarters · filed 2018-02-27
$13.69M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$3.06M
10-Q · filed 2017-05-08
$6.68M
derived: sum of 2 quarters · filed 2018-02-27
$10.63M
derived: sum of 3 quarters · filed 2018-02-27
$15.92M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$3.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$7.58M
derived: sum of 2 quarters · filed 2018-02-27
$12.86M
derived: sum of 3 quarters · filed 2018-02-27
$16.91M
10-K · filed 2018-02-27
2015-09-30$3.95M
10-Q · filed 2016-11-03
$9.24M
derived: sum of 2 quarters · filed 2016-11-03
$13.29M
10-Q · filed 2016-11-03
$16.65M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$5.29M
10-Q · filed 2016-08-04
$9.34M
10-Q · filed 2016-08-04
$12.70M
derived: sum of 3 quarters · filed 2017-03-01
$15.93M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$4.05M
10-Q · filed 2016-05-05
$7.42M
derived: sum of 2 quarters · filed 2017-03-01
$10.64M
derived: sum of 3 quarters · filed 2017-03-01
$14.38M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$6.59M
derived: sum of 2 quarters · filed 2017-03-01
$10.33M
derived: sum of 3 quarters · filed 2017-03-01
$12.96M
10-K · filed 2017-03-01
2014-09-30$3.23M
10-Q · filed 2015-11-04
$6.96M
derived: sum of 2 quarters · filed 2015-11-04
$9.59M
10-Q · filed 2015-11-04
$13.21M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$3.73M
10-Q · filed 2015-08-06
$6.36M
10-Q · filed 2015-08-06
$9.98M
derived: sum of 3 quarters · filed 2016-02-25
$13.61M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$2.63M
10-Q · filed 2015-05-07
$6.25M
derived: sum of 2 quarters · filed 2016-02-25
$9.88M
derived: sum of 3 quarters · filed 2016-02-25
$13.42M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$3.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$7.25M
derived: sum of 2 quarters · filed 2016-02-25
$10.78M
derived: sum of 3 quarters · filed 2016-02-25
$13.28M
10-K · filed 2016-02-25
2013-09-30$3.63M
10-Q · filed 2014-11-07
$7.17M
derived: sum of 2 quarters · filed 2014-11-07
$9.67M
10-Q · filed 2014-11-07
$11.18M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$3.54M
10-Q · filed 2014-08-12
$6.03M
10-Q · filed 2014-08-12
$7.55M
derived: sum of 3 quarters · filed 2015-03-02
$8.99M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$2.50M
10-Q · filed 2014-05-15
$4.01M
derived: sum of 2 quarters · filed 2015-03-02
$5.46M
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$2.96M
derived: sum of 2 quarters · filed 2015-03-02
$5.56M
10-K · filed 2015-03-02
2012-09-30$1.44M
10-Q · filed 2013-11-14
$4.04M
10-Q · filed 2013-11-14
2011-12-31$4.76M
10-K · filed 2014-03-17